India cracks down on manufacturers; Vivimed says FDA OK with API plant in Spain;

> India's Drugs Control Administration issued show cause notices to 23 drug manufacturers and seized drugs from two others while inspecting 25 facilities last month. Report

> India's Vivimed Labs says its API plant in Spain successfully passed an FDA inspection. Report

> Israel-based SciVac Therapeutics says it has resumed production of its hepatitis B vaccine at a plant in British Columbia, which it earlier stopped because some vials had been damaged during labeling. Release

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.